H1B Salary Data

Home › Employers › Applied StemCell Inc.

Applied StemCell Inc.: H-1B salaries and sponsorship

Applied StemCell Inc. filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $77,800.

Applications (LCAs)4
Certified4
Employer addressMilpitas, CA
H-1B dependent employerNo
Median offered salary$77,800
Middle half of salaries$72,201–$80,300
10th–90th percentile$66,084–$80,840

Does Applied StemCell Inc. sponsor H-1B visas?

Applied StemCell Inc. filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on May 13, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Research Associate2$77,800
Public Relations Specialist1$62,005
Group Lead, Cell Biology1$81,200

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$75,600
FY20243$80,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Public Relations Specialist$62,005
Level I
Milpitas, CAMay 13, 2024Oct 1, 2024Certified
Research Associate$80,000
Level IV
Milpitas, CAApr 12, 2024Oct 1, 2024Certified
Group Lead, Cell Biology$81,200
Level IV
Milpitas, CAApr 12, 2024Oct 1, 2024Certified
Research Associate$75,600
Level IV
Milpitas, CAMay 22, 2023Oct 1, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).